Abstract

Pterygota macrocarpa and Cola gigantea are African medicinal plants used in traditional medicine for the treatment of sores, skin infections, and other inflammatory conditions including pains. This study therefore aims at investigating the antimicrobial properties of ethanol leaf and stem bark extracts of P. macrocarpa and C. gigantea using the agar diffusion and the micro-dilution techniques and also determining the anti-inflammatory properties of the extracts of these plants in carrageenan-induced foot edema in seven-day old chicks. The minimum inhibitory concentration of both ethanol leaf and bark extracts of P. macrocarpa against the test organisms was from 0.125 to 2.55 mg/mL and that of C. gigantea extracts was 0.125 to 2.75 mg/mL. Extracts with concentration of 50 mg/mL were most active against the test organisms according to the agar diffusion method. All the extracts of P. macrocarpa and C. gigantea at 30, 100, and 300 mg/kg body weight except ethanol leaf extract of C. gigantea exhibited significant anti-inflammatory effects (P ≤ 0.001).

Highlights

  • The search for newer antimicrobial agents from various sources has become imperative because of the emergence of resistance strains of microorganisms against orthodox antibiotics especially difficulty to treat infections from resistant strains of bacteria [1] and the fact that the number of scientists who are developing new antibacterial agents has dwindled, even as bacteria evolve ever more clever mechanisms of resistance to antibiotics [2]

  • The aim of this study is to investigate the antimicrobial and anti-inflammatory activities of ethanol stem bark and leaf extracts of P. macrocarpa and C. gigantea

  • Various quantities of the ethanol leaf extract (CGLE) and ethanol stem bark extract (CGBE) of C. gigantea and ethanol leaf extract (PMLE) and ethanol stem bark extract (PMBE) of P. macrocarpa were dissolved in normal saline and methanol for acute anti-inflammatory and antimicrobial determinations, respectively

Read more

Summary

Introduction

The search for newer antimicrobial agents from various sources has become imperative because of the emergence of resistance strains of microorganisms against orthodox antibiotics especially difficulty to treat infections from resistant strains of bacteria [1] and the fact that the number of scientists who are developing new antibacterial agents has dwindled, even as bacteria evolve ever more clever mechanisms of resistance to antibiotics [2]. In Africa and other developing countries, it is estimated that 70 to 80% of people rely on traditional healers and herbal practitioners for their health needs [3, 4] and medicinal plants are the main source of remedies used in this therapy. Some of these medicinal plants are used for the management of several different disease conditions such as bacterial infections, parasitic infections, skin diseases, hypertension, pains, and inflammation such as rheumatoid arthritis [5,6,7,8]. Cryptolepine, an alkaloid from Cryptolepine sanguinolenta, has been shown to possess antimicrobial and antiplasmodial activities which have gone to confirm its medicinal uses as antiinfective and antimalarial agent [10, 11]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.